Home
Benjamin L. Palleiko, CEO: KalVista Pharmaceuticals KALV Sell · Filed 25/11/26
Trade details
- Type
- Insider sale
- Amount
- $147,143
- Shares · price
- 10,940 sh · $13.45 a share
- Held after
- 416,189 sh
- Person
- Benjamin L. PalleikoCEO
- Trade date
- 25/11/24
- Filed
- 25/11/26
- Days to filing
- 2 days
Sold 2.6% of holdings
- Share of holding sold
- 2.6%
KalVista Pharmaceuticals trades, last 26 weeks
What else happened in KalVista Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 25/10/25~25/12/24Benjamin L. Palleiko's recent trades
- Benjamin L. Palleiko
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$292.6K
10,926 sh
$292.6K
Filed 05/26
Traded 05/22
- Benjamin L. Palleiko
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$30.2K
1,129 sh
$30.2K
Filed 05/19
Traded 05/18
- Benjamin L. Palleiko
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$88.7K
3,322 sh
$88.7K
Filed 05/13
Traded 05/12
- Benjamin L. Palleiko
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$193.1K
9,550 sh
$193.1K
Filed 04/20
Traded 04/17
- Benjamin L. Palleiko
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$107.6K
6,693 sh
$107.6K
Filed 03/10
Traded 03/09